Cardiology articles from across Nature Portfolio

In the CLEAR Outcomes trial, bempedoic acid lowered plasma LDL-cholesterol levels and reduced the incidence of major adverse cardiovascular events in individuals who were intolerant to statin therapy.

Tricuspid transcatheter edge-to-edge repair in patients with severe tricuspid regurgitation improved quality of life and reduced disease severity compared with medical therapy

A wrist-worn, transdermal sensor can be used to measure plasma levels of cardiac troponin I, potentially facilitating the diagnosis of myocardial infarction.

In patients with complex coronary lesions, percutaneous coronary intervention guided by intravascular imaging improved cardiovascular outcomes compared with percutaneous coronary intervention guided by angiography.

MK-0616, an oral inhibitor of PCSK9, safely and effectively lowers plasma levels of LDL cholesterol in a dose-dependent manner in patients with hypercholesterolaemia.

Immediate complete revascularization is as safe and effective as staged complete revascularization in patients with acute coronary syndrome and multivessel disease, according to findings from the BIOVASC trial.